Pratik Shah

Insider Reports History

Location
La Jolla, CA
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pratik Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARS Pharmaceuticals, Inc. Director Common Stock 4.47M $45M $10.05 12 Nov 2025 By The Pratik Shah Living Trust dated June 15, 2011
Design Therapeutics, Inc. President, CEO and Chairperson, Director Stock option (right to buy) 525K 09 Dec 2025 Direct
ARS Pharmaceuticals, Inc. Director Stock Option (right to buy) 30K 25 Jun 2025 Direct

Insider Reports Filed by Pratik Shah

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DSGN Design Therapeutics, Inc. 09 Dec 2025 2 $0 4 President, CEO and Chairperson, Director 11 Dec 2025, 16:30
SPRY ARS Pharmaceuticals, Inc. 12 Nov 2025 2 $0 4 Director 14 Nov 2025, 18:41
SPRY ARS Pharmaceuticals, Inc. 25 Jun 2025 1 $0 4 Director 27 Jun 2025, 16:30
DSGN Design Therapeutics, Inc. 02 Jan 2025 1 $0 4 President, CEO and Chairperson, Director 06 Jan 2025, 19:00
SPRY ARS Pharmaceuticals, Inc. 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 17:00
SPRY ARS Pharmaceuticals, Inc. 13 Jun 2024 2 $0 4 Director 17 Jun 2024, 18:39
SPRY ARS Pharmaceuticals, Inc. 07 Jun 2024 1 $0 4 Director, 10%+ Owner 07 Jun 2024, 21:11
SPRY ARS Pharmaceuticals, Inc. 04 Jun 2024 1 $0 4/A Director, 10%+ Owner 07 Jun 2024, 21:09
SPRY ARS Pharmaceuticals, Inc. 04 Jun 2024 3 $0 4 Director, 10%+ Owner 06 Jun 2024, 16:32
DSGN Design Therapeutics, Inc. 01 Sep 2023 3 $0 4 President, CEO and Chairperson, Director 05 Sep 2023, 17:33
SPRY ARS Pharmaceuticals, Inc. 27 Jun 2023 1 $0 4 Director, 10%+ Owner 28 Jun 2023, 21:00
DSGN Design Therapeutics, Inc. 01 Feb 2023 1 $0 4 Executive Chairperson, Director 03 Feb 2023, 15:40
SPRY ARS Pharmaceuticals, Inc. 08 Nov 2022 2 $0 4 Director, 10%+ Owner 10 Nov 2022, 17:00
SPRY ARS Pharmaceuticals, Inc. 08 Nov 2022 0 $0 3 Director, 10%+ Owner 10 Nov 2022, 16:01
DSGN Design Therapeutics, Inc. 01 Feb 2022 1 $0 4 Executive Chairperson, Director 02 Feb 2022, 18:50